Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Initiation of NOBLE Registry for Telix's TLX599-CDx SPECT in prostate cancer

April 21, 2021

New molecular imaging and therapy trials open at Hoag

April 21, 2021

Medshine Discovery patent describes LSD1 inhibitors

April 21, 2021

New GTPase KRAS mutant inhibitors presented by BeiGene

April 21, 2021

Fujifilm divulges FGFR inhibitors

April 21, 2021

Sumitomo Dainippon Pharma patents new compounds for cancer

April 21, 2021

Discovery and preclinical characterization of novel KRAS G12C inhibitor, LY-3537982

April 21, 2021

FDA allows Vincerx Pharma to conduct phase Ib study of VIP-152 in CLL and Richter syndrome

April 21, 2021

Positive interim data presented from phase I portion of the AUGMENT-101 study of SNDX-5613

April 21, 2021

Revolution Medicines targets SOS-1 with new compound RMC-0331 for RAS-driven cancers

April 21, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...